Leqembi
Lecanemab · Eisai Inc.
PRESCRIPTION ONLY (USA)Leqembi ingredients
| Active ingredient | Strength |
|---|---|
| Lecanemab | 100 mg/mL |
What Leqembi is used for
Leqembi is a specialist medicine (amyloid beta-directed antibody). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Leqembi
- Generic name
- Lecanemab
- Made by
- Eisai Inc.
- Forms
- Injection, Solution
- Given
- Intravenous
- Drug class
- Amyloid Beta-directed Antibody
- FDA approval
- Biologic licence (BLA) BLA761269
- On the US market since
- 2023
Official information
- Leqembi prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Lecanemab)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Leqembi?
Leqembi (Lecanemab) is a specialist medicine made by Eisai Inc., approved by the US FDA.
What are the ingredients of Leqembi?
Leqembi contains Lecanemab (100 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA